NexturnBioscience Co. Ltd (089140) - Total Liabilities

Latest as of September 2025: ₩128.65 Billion KRW ≈ $87.19 Million USD

Based on the latest financial reports, NexturnBioscience Co. Ltd (089140) has total liabilities worth ₩128.65 Billion KRW (≈ $87.19 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore NexturnBioscience Co. Ltd (089140) net asset momentum to track the company's year-over-year net asset growth rate.

NexturnBioscience Co. Ltd - Total Liabilities Trend (2014–2024)

This chart illustrates how NexturnBioscience Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. See NexturnBioscience Co. Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

NexturnBioscience Co. Ltd Competitors by Total Liabilities

The table below lists competitors of NexturnBioscience Co. Ltd ranked by their total liabilities.

Company Country Total Liabilities
Rubberex Corporation M Bhd
KLSE:7803
Malaysia RM27.27 Million
Firefly Neuroscience, Inc.
NASDAQ:AIFF
USA $2.75 Million
Domo Activos Socimi SA
MC:DOMO
Spain €215.90K
Condor Resources Inc
V:CN
Canada CA$217.60K
All In! Games S.A.
WAR:ALG
Poland zł26.57 Million
Betonjaya Manunggal Tbk
JK:BTON
Indonesia Rp148.36 Billion
Brite Tech Bhd
KLSE:0011
Malaysia RM70.81 Million

Liability Composition Analysis (2014–2024)

This chart breaks down NexturnBioscience Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see NexturnBioscience Co. Ltd (089140) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.07 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.84 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.35 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how NexturnBioscience Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for NexturnBioscience Co. Ltd (2014–2024)

The table below shows the annual total liabilities of NexturnBioscience Co. Ltd from 2014 to 2024.

Year Total Liabilities Change
2024-12-31 ₩96.41 Billion
≈ $65.34 Million
-9.03%
2023-12-31 ₩105.98 Billion
≈ $71.82 Million
+15.22%
2022-12-31 ₩91.98 Billion
≈ $62.34 Million
+99.04%
2021-12-31 ₩46.21 Billion
≈ $31.32 Million
+1689.03%
2020-12-31 ₩2.58 Billion
≈ $1.75 Million
-48.45%
2019-12-31 ₩5.01 Billion
≈ $3.40 Million
-72.17%
2018-12-31 ₩18.01 Billion
≈ $12.20 Million
+502.69%
2017-12-31 ₩2.99 Billion
≈ $2.02 Million
-65.43%
2016-12-31 ₩8.64 Billion
≈ $5.86 Million
+172.72%
2015-12-31 ₩3.17 Billion
≈ $2.15 Million
-28.10%
2014-12-31 ₩4.41 Billion
≈ $2.99 Million
--

About NexturnBioscience Co. Ltd

KQ:089140 Korea Machinery, Tools, Heavy Vehicles, Trains & Ships
Market Cap
$15.20 Million
₩22.43 Billion KRW
Market Cap Rank
#25906 Global
#1932 in Korea
Share Price
₩2150.00
Change (1 day)
+6.97%
52-Week Range
₩1853.00 - ₩2995.00
All Time High
₩56500.00
About

Nexturn Co.,Ltd. develops and produces CNC automatic lathe machines in Korea and internationally. It provides CNC swiss-type automatic lathe products, high temperature display glass press equipment, and automatic line-up robots, as well as an intelligent intervention robot system based on robot 3D cardiovascular visualization technology. The company was formerly known as KMT Incorporated and chan… Read more